| 000 | 01653 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514073156.0 | ||
| 264 | 0 | _c20040430 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a1071-412X | ||
| 024 | 7 |
_a10.1128/cdli.10.4.664-669.2003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJeyarajah, D Rohan | |
| 245 | 0 | 0 |
_aInfection by gram-negative organisms via the biliary route results in greater mortality than portal venous infection. _h[electronic resource] |
| 260 |
_bClinical and diagnostic laboratory immunology _cJul 2003 |
||
| 300 |
_a664-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aCholangitis _xetiology |
| 650 | 0 | 4 |
_aCholestasis _xcomplications |
| 650 | 0 | 4 |
_aEscherichia coli _xphysiology |
| 650 | 0 | 4 |
_aEscherichia coli Infections _xetiology |
| 650 | 0 | 4 |
_aHepatitis _xetiology |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aInterleukins _xbiosynthesis |
| 650 | 0 | 4 | _aLigation |
| 650 | 0 | 4 |
_aLipopolysaccharides _xadministration & dosage |
| 650 | 0 | 4 |
_aLiver _xmicrobiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 | _aModels, Animal |
| 650 | 0 | 4 | _aPortal Vein |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 700 | 1 | _aKielar, Mariusz L | |
| 700 | 1 | _aFrantz, Nicole | |
| 700 | 1 | _aLindberg, Guy | |
| 700 | 1 | _aLu, Christopher Y | |
| 773 | 0 |
_tClinical and diagnostic laboratory immunology _gvol. 10 _gno. 4 _gp. 664-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/cdli.10.4.664-669.2003 _zAvailable from publisher's website |
| 999 |
_c12633930 _d12633930 |
||